This study not only fills a research gap by presenting a strategy for CCK2R-targeted radiotherapy that targets poorly differentiated and highly proliferative tumor cell populations but also reveals an mTOR inhibitor-based radiosensitization strategy; overall, this study provides experimental evidence and potential clinical applications for optimizing CCK2R-targeted radiotherapy. Here, MTOR is linked to neoplasm.